You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 11,510,984


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,510,984 protect, and when does it expire?

Patent 11,510,984 protects PEDMARK and is included in one NDA.

This patent has twenty-four patent family members in twelve countries.

Summary for Patent: 11,510,984
Patent landscape, scope, and claims:
Title:Anhydrous sodium thiosulfate and formulations thereof
Abstract:Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
Inventor(s):Lovelace Thomas Claiborne, Moore, III Joseph Alexander, Lee Christopher McKinnon, Kirschner Daniel Logan
Assignee:Fennec Pharmaceuticals, Inc.
Application Number:US17849477
Patent Claim Types:
see list of patent claims
 

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,510,984

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Fennec Pharms Inc PEDMARK sodium thiosulfate SOLUTION;INTRAVENOUS 212937-001 Sep 20, 2022 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,510,984

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2019299216 ⤷  Subscribe
Australia 2019299217 ⤷  Subscribe
Brazil 112021000021 ⤷  Subscribe
Brazil 112021000022 ⤷  Subscribe
Canada 3103982 ⤷  Subscribe
Canada 3103986 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.